Showing 1 - 13 results of 13 for search 'Stefania Bellone', query time: 0.05s Refine Results
  1. 1
    Increased serum 1,25-dihydroxyvitamin D levels in gynecologic cancer patients with Post-Acute-Covid-Sequela (PASC)/Long COVID

    Increased serum 1,25-dihydroxyvitamin D levels in gynecologic cancer patients with Post-Acute-Covid-Sequela (PASC)/Long COVID by Stefania Bellone, Eric E. Siegel, Alessandro D. Santin

    Published 2023
    Connect to this object online.
    Book
    Save to List
    Saved in:
  2. 2
    Regression of metastatic, radiation/chemotherapy-resistant uterine serous carcinoma overexpressing HER2/neu with trastuzumab emtansine (TDM-1)

    Regression of metastatic, radiation/chemotherapy-resistant uterine serous carcinoma overexpressing HER2/neu with trastuzumab emtansine (TDM-1) by Alessandro D. Santin, Stefania Bellone, Natalia Buza, Peter E. Schwartz

    Published 2017
    Connect to this object online.
    Book
    Save to List
    Saved in:
  3. 3
    Utility of next generation sequencing to unequivocally establish clonality in synchronous vs metastatic endometrial and ovarian carcinomas

    Utility of next generation sequencing to unequivocally establish clonality in synchronous vs metastatic endometrial and ovarian carcinomas by Michelle Greenman, Stefania Bellone, Tobias Hartwich, Natalia Buza, Alessandro D. Santin

    Published 2024
    Connect to this object online.
    Book
    Save to List
    Saved in:
  4. 4
    Improved survival of patients with hypermutation in uterine serous carcinoma

    Improved survival of patients with hypermutation in uterine serous carcinoma by Alessandro D. Santin, Stefania Bellone, Floriana Centritto, Joseph Schlessinger, Richard Lifton

    Published 2015
    Connect to this object online.
    Book
    Save to List
    Saved in:
  5. 5
    Increased von Willebrand and Factor VIII plasma levels in gynecologic patients with Post-Acute-COVID-Sequela (PASC)/Long COVID

    Increased von Willebrand and Factor VIII plasma levels in gynecologic patients with Post-Acute-COVID-Sequela (PASC)/Long COVID by Stefania Bellone, Eric R. Siegel, David E. Scheim, Alessandro D. Santin

    Published 2024
    Connect to this object online.
    Book
    Save to List
    Saved in:
  6. 6
    Binimetinib (MEK162) in recurrent low-grade serous ovarian cancer resistant to chemotherapy and hormonal treatment

    Binimetinib (MEK162) in recurrent low-grade serous ovarian cancer resistant to chemotherapy and hormonal treatment by Chanhee Han, Stefania Bellone, Luca Zammataro, Peter E. Schwartz, Alessandro D. Santin

    Published 2018
    Connect to this object online.
    Book
    Save to List
    Saved in:
  7. 7
    Sacituzumab govitecan in heavily pretreated, platinum-resistant high grade serous ovarian cancer

    Sacituzumab govitecan in heavily pretreated, platinum-resistant high grade serous ovarian cancer by Michelle Greenman, Stefania Bellone, Cem Demirkiran, Tobias Max Philipp Hartwich, Alessandro D. Santin

    Published 2024
    Connect to this object online.
    Book
    Save to List
    Saved in:
  8. 8
    Trastuzumab deruxtecan in recurrent uterine serous carcinoma resistant to trastuzmab based-chemotherapy

    Trastuzumab deruxtecan in recurrent uterine serous carcinoma resistant to trastuzmab based-chemotherapy by Blair McNamara, Stefania Bellone, Cem Demirkiran, Tobias Max Philipp Hartwich, Alessandro D. Santin

    Published 2023
    Connect to this object online.
    Book
    Save to List
    Saved in:
  9. 9
    Pembrolizumab and lenvatinib in recurrent ovarian clear cell carcinoma resistant to chemotherapy

    Pembrolizumab and lenvatinib in recurrent ovarian clear cell carcinoma resistant to chemotherapy by Blair McNamara, Stefania Bellone, Cem Demirkiran, Tobias Max Philipp Hartwich, Alessandro D. Santin

    Published 2023
    Connect to this object online.
    Book
    Save to List
    Saved in:
  10. 10
    Sacituzumab Govitecan (IMMU-132) in treatment-resistant uterine serous carcinoma: A case report

    Sacituzumab Govitecan (IMMU-132) in treatment-resistant uterine serous carcinoma: A case report by Chanhee Han, Stefania Bellone, Peter E. Schwartz, Serengulam V. Govindan, Robert M. Sharkey, David M. Goldenberg, Alessandro D. Santin

    Published 2018
    Connect to this object online.
    Book
    Save to List
    Saved in:
  11. 11
    Selection of HER2/NEU negative tumor cells as a mechanism of resistance to trastuzumab in uterine serous carcinoma

    Selection of HER2/NEU negative tumor cells as a mechanism of resistance to trastuzumab in uterine serous carcinoma by Silvia Pelligra, Natalia Buza, Pei Hui, Stefania Bellone, Burak Zeybek, Elena Ratner, Peter E. Schwartz, Giovanni Scambia, Alessandro D. Santin

    Published 2020
    Connect to this object online.
    Book
    Save to List
    Saved in:
  12. 12
    Corrigendum to "Phase II evaluation of copanlisib, a selective inhibitor of Pi3kca, in patients with persistent or recurrent endometrial carcinoma harboring PIK3CA hotspot mutations: An NRG oncology study (NRG-GY008)" [Gynecol. Oncol. Rep. 31 (2020) 100532]

    Corrigendum to "Phase II evaluation of copanlisib, a selective inhibitor of Pi3kca, in patients with persistent or recurrent endometrial carcinoma harboring PIK3CA hotspot mutation... by Alessandro D. Santin, Virginia Filiaci, Stefania Bellone, Roisin O'Cearbhaill, Elena S. Ratner, Cara A. Mathews, Guilherme Cantuaria, Camille C. Gunderson, Teresa Rutledge, Barbara M. Buttin, Heather A. Lankes, Michael J. Birrer

    Published 2020
    Connect to this object online.
    Book
    Save to List
    Saved in:
  13. 13
    Phase II evaluation of copanlisib, a selective inhibitor of Pi3kca, in patients with persistent or recurrent endometrial carcinoma harboring PIK3CA hotspot mutations: An NRG Oncology study (NRG-GY008)

    Phase II evaluation of copanlisib, a selective inhibitor of Pi3kca, in patients with persistent or recurrent endometrial carcinoma harboring PIK3CA hotspot mutations: An NRG Oncolo... by Alessandro D. Santin, Virginia Filiaci, Stefania Bellone, Elena S. Ratner, Cara A. Mathews, Guilherme Cantuaria, Camille C. Gunderson, Teresa Rutledge, Barbara M. Buttin, Heather A. Lankes, Michael Frumovitz, Samir N. Khleif, Warner K. Huh, Michael J. Birrer

    Published 2020
    Connect to this object online.
    Book
    Save to List
    Saved in:

Search Tools: